Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / ADR
-
Total 13F shares
-
208,488,226
-
Share change
-
+1,576,465
-
Total reported value
-
$8,027,519,507
-
Put/Call ratio
-
96%
-
Price per share
-
$38.51
-
Number of holders
-
752
-
Value change
-
+$51,431,248
-
Number of buys
-
261
-
Number of sells
-
393
Institutional Holders of GLAXOSMITHKLINE PLC - ADR (GSK) as of Q4 2016
As of 31 Dec 2016 GLAXOSMITHKLINE PLC - ADR (GSK) had 752 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 208,488,226 shares of stock of the company.
Largest 10 holders included FMR LLC, Fisher Asset Management, LLC, STATE STREET CORP, PRICE T ROWE ASSOCIATES INC /MD/, WELLS FARGO & COMPANY/MN, ROYAL BANK OF CANADA, HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC, Bank of New York Mellon Corp, BANK OF AMERICA CORP /DE/, and MORGAN STANLEY.
This table shows 754 institutional shareholders of the security as of 31 Dec 2016.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.